The evaluation of these vectors, in both in vitro and in vivo CCA models, revealed that the transduction with these adenoviral vectors resulted in an increased expression of OCT1, which selectively occurred in the plasma membrane of CCA cells, but not in the healthy liver tissue. This evidence concerns the gene SLC22A1 and cholangiocarcinoma.